Intercept Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This dashboard includes a Q&A table about Intercept Pharmaceuticals Inc. If you work at Intercept Pharmaceuticals Inc and you wish to use your ESG rating, please get in touch. The page displays a zero-cost Environmental, Social and Governance analysis for Intercept Pharmaceuticals Inc.
Intercept Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 4.0, social score of 3.2 and governance score of 1.6.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
| 1336 | Sensorion SA | 3.0 | Medium |
| 1353 | Intercept Pharmaceuticals Inc | 2.9 | Medium |
| 1353 | Caribou Biosciences Inc | 2.9 | Medium |
| 1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Intercept Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Intercept Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Intercept Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Intercept Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Intercept Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Intercept Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Intercept Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in New York, New York.